|
0
|
|
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.
(pnas.org)
|
Wang X
…
Lu X
PNAS
2026-07-01
|
#cancer
#apoptosis
#synthetic lethality
#signaling
#immunotherapy
|
|
0
|
|
Casdatifan shows durable response linked to HIF-2alpha biology in kidney cancer.
(nature.com)
|
Choueiri TK
…
McKay RR
Nature
2026-07-01
|
#cancer
#kidney
#hif-signaling
#immunotherapy
#biomarker
|
|
0
|
|
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.
(nature.com)
|
Vaquero-Siguero N
…
Jackstadt R
Nature
2026-07-01
|
#cancer
#metastasis
#amr
#plasticity
#immunotherapy
|
|
0
|
|
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.
(nature.com)
|
Savage N
…
Singh SK
Nature
2026-07-01
|
#immunotherapy
#car-t
#glioblastoma
#macrophage
#microenvironment
|
|
0
|
|
Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.
(academic.oup.com)
|
Huggins J
…
Andermann TM
Open Forum Infectious Diseases
2026-07-01
|
#infection
#immunotherapy
#cancer
#adverse events
|
|
0
|
|
Complement Factor H-Based Therapeutics: A Comprehensive Overview.
(onlinelibrary.wiley.com)
|
Hamers SMWR
…
Pouw RB
European Journal of Immunology
2026-07-01
|
#complement
#immunotherapy
#therapeutics
#innate immunity
|
|
0
|
|
Efficacy of Immunoglobulin Therapy for Secondary Prevention of Congenital Cytomegalovirus Infection: A Systematic Review and Meta-Analysis.
(academic.oup.com)
|
Gutowska K
…
Issat T
Open Forum Infectious Diseases
2026-07-01
|
#meta-analysis
#pregnancy
#cytomegalovirus
#prevention
#immunotherapy
|
|
0
|
|
Engineering Soluble Recombinant BCMA for Ide-Cel Labeling.
(onlinelibrary.wiley.com)
|
Nguyen LPV
…
Legembre P
European Journal of Immunology
2026-07-01
|
#immunotherapy
#car-t
#cancer
#protein design
#myeloma
|